Animal Vaccines Market Expected to Reach US ~$16.27 billion and CAGR 7.5% by 2028 – Polaris Market Research

Drone Taxi Market

The global Animal Vaccines Market size is expected to reach USD 16.27 billion by 2028 according to a new study by Polaris Market Research.

The increasing cases of zoonotic diseases and the rising number of infectious diseases in different types of meat that are slowing the growth of the industry will be the main factors responsible for the development of the global market. The emergence of modern recombinant injections and the investment by governments in mass immunization programs are anticipated to fuel the market growth further.

Request Sample Copy of Research Report @        

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

Zoonotic diseases have been shared across the globe in the past few decades, and more than half of the emerging infectious diseases worldwide originated from pets. Many diseases have been transmitted from pets to humans, such as Swine flu. Hence, it is necessary to vaccinate food and pets to prevent any such disease from spreading in the coming years.

The introduction of new and innovative technologies such as recombinant serums will develop innovative products in the coming years. These inoculations can overcome the limitations of conventional medicines and hence will be widely adopted. For instance, in April 2021, ICAR-CIBA launched a recombinant vaccine CIBA-Nodavac-R against nervous necrosis virus (NNV), which affects marine, brackish water, and freshwater fish that results in 100 % mortality in early juvenile and larval stages.

See also  Data Center Interconnect Market Growing Popularity And Emerging Trends With Key Players Till 2032

Numerous developments are taking place in the market with the launch of many medications and acquisitions, funding, and collaborations. Zoetis launched the porcine vaccine CircoMax Myco in May 2021, the only vaccine for the protection against Mycoplasma hyopneumoniae and PCV2. Applied LifeSciences & Systems (ALSS) raised USD 7 million in recent funding in May 2021 to automate poultry vaccination systems.

Buy a Premium Report –

Market participants include Zoetis, Biogénesis Bagó, Boehringer Ingelheim International GmbH, Ceva, Elanco, Indian Immunologicals Ltd., Intas Pharmaceuticals Ltd., Merck & Co., Inc., Neogen Corporation, Ourofino Saúde Animal, Phibro Animal Health Corporation, and Virbac are some of the key players operating in the global market.

Inquire more about this report before purchasing @        

(You may enquire about a reported quote OR available discount offers to our sales team before purchase.)

Polaris Market research has segmented the animal vaccines market report on the basis of product, animal type, and region

 Animal Vaccines, Product Outlook (Revenue – USD Million, 2016 – 2028)

  • Attenuated live vaccines
  • Inactivated vaccines
  • Subunit vaccines
  • DNA vaccines
  • Recombinant vaccines

Animal Vaccines, Animal Type Outlook (Revenue – USD Million, 2016 – 2028)

  • Poultry
    • Infectious bronchitis
    • Avian influenza
    • Marek’s disease
    • Newcastle disease
    • Salmonella
    • Others
  • Aqua
    • Bacterial
    • Viral
    • Others
  • Ruminants
    • Foot & Mouth Disease (FMD)
    • Lumpy skin
    • Rotavirus
    • Coronavirus
    • Coli
    • Others
  • Companion
    • Canine
      • Distemper
      • Kennel cough
      • Parvovirus
      • Canine herpes
      • Lyme disease
      • Rabies
    • Feline
      • Rhinotracheitis
      • Calicivirus
      • Coronavirus
      • Panleukopenia
      • Rabies
    • Swine
      • Swine influenza
      • Classical Swine Fever (CSF)
      • Porcine Parvovirus (PPV)
      • Porcine Circovirus Type 2 (PCV2)
      • Hyo
      • Actinobacillus Pleuropneumoniae
      • PRRS
      • Foot & mouth disease
      • Pseudorabies
      • PEDV (coronavirus)
      • Others
See also  Animal Vaccines Market Expected to Reach US ~$16.27 Billion and CAGR 7.5% by 2030 - Polaris Market Research

Browse detailed report with in-depth TOC – Animal Vaccines Market

About Us:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

Contact Us:

Polaris Market Research

Phone: +1-929-297-9727